Serumanti-PLA2R antibody predicted treatment outcome in idiopathic membranous nephropathy

Objective To explore the predictive value of serum phospholipase A2 receptor antibody in determining the efficacy of rituximab in the treatment of idiopathic membranous nephropathy(IMN).Methods From August 1,2017 to May 31,2020,a total of 120 IMN patients received rituximab for the first time or dur...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Xue-qin, Jiang Hong, Yang Shu-fen, Zhao Hong-juan, Lu Chen
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2021-01-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails?columnId=57904269&Fpath=home&index=0
Tags: Add Tag
No Tags, Be the first to tag this record!